Latisse is the new FDA-approved eyelash growth treatment that has been shown to grow thicker, darker, and longer eyelashes. Today you can allow yourself to look natural without cosmetics and MASCARA.
Latisse is the same formula as Lumigan, Allergan’s eyedrops for glaucoma, which reduces eye pressure but also happens to grow lashes. Both are also known as bimatoprost ophthalmic solution. In early 2009, Allergan introduced the drug as a lash enhancer.
The commercial name of the medication may differ from the brand one. Generic Latisse manufactured by Ajanta is available under commercial name Bimat. Generic Latisse comes with one applicator brush.
However when using Latisse without seeing a doctor, the side effects may come as a big surprise. Among the common Side effects such as eye irritation are of temporary nature and they disappear after first few uses. Darkening of the eyelids close to the application area is also a common side effect. This is reversible by stopping the use of the Latisse solution.
Today you can easily find and buy Generic Latisse online at any online pharmacy store.
But it is insistently recommend to use this drug under doctor supervision only.
“When the F.D.A. approved this product for marketing, they made a determination that the side effects or misuse or inappropriate use could cause harm, and that’s why they restricted it to a prescription drug,” said Carmen A. Catizone, the executive director of the National Association of Boards of Pharmacy, which represents state agencies that regulate pharmacies and pharmacists. “If it was completely safe to use without doctor supervision, they would have deemed it over-the-counter.”
All doctors explain how to use the medication, even though you can easily find this info online.
Some doctors proscribe the medication without careful examination. In order to avoid any side effects that this product might cause you should insist on medical examination.
How to apply:
* Ensure the face is clean, makeup and contact lenses are removed.
* Dispose of the applicator after one use.
* Repeat for the opposite eyelid margin using a new sterile applicator.
For years, credible online pharmacies have charged too much for generic medications. Generics are copycat versions of brand-name drugs, allowed once patents expire. They're clinically identical, but much cheaper to produce. Clinically, there is no difference!
No one outside the industry knows the precise manufacturing cost. Generic drugs online are cheaper than their brand name equivalents because the manufacturers do not have the research and development costs associated with bringing new drugs to the market.
What we have is access to brand name as well as generic over-the-counter medication with choice for patients and competition between manufacturers, which brings prices down.
Manufacturers determine what to charge for generic drugs and governments set the prices they will pay for publicly funded medications.
Under the deal, the cost of generic prescription drugs will drop from 65 per cent of the brand name cost to 35 per cent.
Studies suggest a fair estimate would be 35 per cent or less of the brand-name equivalent. Yet pharmacies have been collaborating with manufacturers to charge 65 per cent of the patent-protected medications' prices.
The government's clean-up of generic online pharmaceuticals is an excellent start.
The drop started from Canada. "By requiring the generic drug industry to reduce its excessive prices, the government is doing its job to ensure the sustainability of Quebec's Prescription Drug Insurance Plan," stated Rx&D president Russell Williams, noting that the generic drugs sold in Canada are among the most expensive in the world.
British Columbia is joining Ontario in cracking down on the rising cost of generic prescription drugs. But the province is avoiding the kind of highly public fight Ontario’s government had with the country’s largest drug store chains by offsetting lower revenue with new funding to expand pharmacy services, sources say.
British Columbia spends more than $900 million annually on prescription drugs through its PharmaCare program, The Globe and Mail said. Generic drugs are capturing a greater percentage of that amount, totaling $286 million in fiscal year 2008-09.
The B.C. government will announce on Friday that it will cut the price of generic drugs by reducing rebates manufacturers pay to pharmacies in return for selling their products, industry sources familiar with the plan said. Unlike Ontario, British Columbia will not abolish the rebates altogether, the sources said.